6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Cannabis
Cannabis (popularly known as marijuana) is a hallucinogenic plant with over 500 components, 104 of which have been discovered so far. On the illicit drug market, there are numerous cannabis preparations available, including hashish, herbal cannabis (leaves and flowers), and oils.
Cannabis's therapeutic applications include: THC is the psychoactive component of cannabis which causes the drunkenness sought by many users. The American Academy of Neurology conducted a systematic assessment of publications on the use of cannabis in the management of multiple sclerosis, neurological diseases, and epilepsy from 1948 to November 2013. Only oral cannabis extracts (combined THC/CBD or CBD alone) shown efficacy in treating spasticity from lupus and central pain. Marijuana use and its harmful ramifications have grown in recent years.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States